Primary antibody deficiencies

Nature Reviews Immunology

Volumn 13, Issue 7, 2013, Pages 519-533

  Durandy, Anne ^a,b   Kracker, Sven ^a,b   Fischer, Alain ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Hôpital Necker Enfants Malades   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; B LYMPHOCYTE RECEPTOR; BRUTON TYROSINE KINASE; CD19 ANTIGEN; CD20 ANTIGEN; CD40 LIGAND; CHEMOKINE RECEPTOR CXCR5; COMPLEMENT COMPONENT C3D RECEPTOR; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN D; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR FOXO; WISKOTT ALDRICH SYNDROME PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY RESPONSE; AUTOIMMUNITY; B LYMPHOCYTE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CD40 LIGAND DEFICIENCY; COMBINED IMMUNODEFICIENCY; GENETIC ENGINEERING; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOGLOBULIN M DEFICIENCY; INFECTION SENSITIVITY; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIMARY ANTIBODY DEFICIENCY; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; WHIM SYNDROME; WISKOTT ALDRICH SYNDROME;

ANIMALS; B-LYMPHOCYTES; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC DEFICIENCY SYNDROMES;

EID: 84879692472     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3466     Document Type: Review

References (120)

1. Conley, M. E. et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu. Rev. Immunol. 27, 199-227 (2009).
2. Berkowska, M. A., van der Burg, M., van Dongen, J. J. & van Zelm, M. C. Checkpoints of B cell differentiation: visualizing Ig-centric processes. Ann. NY Acad. Sci. 1246, 11-25 (2011).
3. Tangye, S. G., Deenick, E. K., Palendira, U. & Ma, C. S. T cell-B cell interactions in primary immunodeficiencies. Ann. NY Acad. Sci. 1250, 1-13 (2012).
4. Durandy, A., Revy, P. & Fischer, A. Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes). Adv. Immunol. 82, 295-330 (2004).
5. Meffre, E. The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases. Ann. NY Acad. Sci. 1246, 1-10 (2011).
6. Salzer, U. et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 113, 1967-1976 (2009).
7. Conley, M. E. et al. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K. J. Exp. Med. 209, 463-470 (2012).
8. Vetrie, D. et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361, 226-233 (1993).
9. Fruman, D. A. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr. Opin. Immunol. 16, 314-320 (2004).
10. Lopez-Granados, E., Perez de Diego, R., Ferreira Cerdan, A., Fontan Casariego, G. & Garcia Rodriguez, M. C. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J. Allergy Clin. Immunol. 116, 690-697 (2005).
11. Bykowsky, M. J. et al. Discordant phenotype in siblings with X-linked agammaglobulinemia. Am. J. Hum. Genet. 58, 477-483 (1996).
12. Wood, P. M. et al. A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency. J. Pediatr. 139, 148-151 (2001).
13. Hernandez, P. A. et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nature Genet. 34, 70-74 (2003).
14. Derry, J. M., Ochs, H. D. & Francke, U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78, 635-644 (1994).
15. Westerberg, L. et al. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood 105, 1144-1152 (2005).
16. Westerberg, L. S. et al. Wiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and function. Blood 119, 3966-3974 (2012).
17. Becker-Herman, S. et al. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J. Exp. Med. 208, 2033-2042 (2011).
18. Lanzi, G. et al. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP. J. Exp. Med. 209, 29-34 (2012).
19. Zhang, Q. et al. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 361, 2046-2055 (2009).
20. Randall, K. L. et al. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nature Immunol. 10, 1283-1291 (2009).
21. Jabara, H. H. et al. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nature Immunol. 13, 612-620 (2012).
22. Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505 (2010).
23. Nehme, N. T. et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 119, 3458-3468 (2012).
24. Abdollahpour, H. et al. The phenotype of human STK4 deficiency. Blood 119, 3450-3457 (2012).
25. Warnatz, K. et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc. Natl Acad. Sci. USA 106, 13945-13950 (2009).
26. Wang, H. Y. et al. Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK. Proc. Natl Acad. Sci. USA 110, 5127-5132 (2013).
27. van Zelm, M. C. et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354, 1901-1912 (2006).
28. van Zelm, M. C. et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J. Clin. Invest. 120, 1265-1274 (2010).
29. Thiel, J. et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J. Allergy Clin. Immunol. 129, 801-810.e6 (2012).
30. Kuijpers, T. W. et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J. Clin. Invest. 120, 214-222 (2010).
31. Xu, G. L. et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187-191 (1999).
32. de Greef, J. C. et al. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am. J. Hum. Genet. 88, 796-804 (2011).
33. Blanco-Betancourt, C. E. et al. Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. Blood 103, 2683-2690 (2004).
34. Picard, C. et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N. Engl. J. Med. 360, 1971-1980 (2009).
35. Feske, S. et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179-185 (2006).
36. Stepensky, P. et al. Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects. J. Allergy Clin. Immunol. 131, 477-485.e1 (2013).
37. Snow, A. L. et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J. Exp. Med. 209, 2247-2261 (2012).
38. Zonana, J. et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-γ (NEMO). Am. J. Hum. Genet. 67, 6 (2000).
39. Hanson, E. P. et al. Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J. Allergy Clin. Immunol. 122, 1169-1177.e16 (2008).
40. Pachlopnik Schmid, J. et al. Polymerase epsilon1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature ('FILS syndrome'). J. Exp. Med. 209, 2323-2330 (2012).
41. Courtois, G. et al. A hypermorphic IκBα mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J. Clin. Invest. 112, 1108-1115 (2003).
42. Ohnishi, H. et al. A rapid screening method to detect autosomal-dominant ectodermal dysplasia with immune deficiency syndrome. J. Allergy Clin. Immunol. 129, 578-580 (2012).
43. Victoratos, P. et al. FDC-specific functions of p55TNFR and IKK2 in the development of FDC networks and of antibody responses. Immunity 24, 65-77 (2006).
44. Boisson, B. et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nature Immunol. 13, 1178-1186 (2012).
45. Alangari, A. et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J. Allergy Clin. Immunol. 130, 481-488.e2 (2012).
46. Lopez-Herrera, G. et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am. J. Hum. Genet. 90, 986-1001 (2012).
47. Ferrari, S. et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl Acad. Sci. USA 98, 12614-12619 (2001).
48. Revy, P. et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102, 565-575 (2000).
49. Imai, K. et al. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Clin. Immunol. 115, 277-285 (2005).
50. Ta, V. T. et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nature Immunol. 4, 843-848 (2003).
51. Imai, K. et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nature Immunol. 4, 1023-1028 (2003).
52. Du, L. et al. Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis. J. Exp. Med. 209, 291-305 (2012).
53. Stewart, G. S. et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 136, 420-434 (2009).
54. Peron, S. et al. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J. Exp. Med. 205, 2465-2472 (2008).
55. Gardes, P. et al. Human MSH6 deficiency is associated with impaired antibody maturation. J. Immunol. 188, 2023-2029 (2012).
56. Avery, D. T. et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207, 155-171 (2010).
57. Kotlarz, D. et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J. Exp. Med. 210, 433-443 (2013).
58. Minegishi, Y. et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448, 1058-1062 (2007).
59. Ozaki, K. et al. A critical role for IL-21 in regulating immunoglobulin production. Science 298, 1630-1634 (2002).
60. Recher, M. et al. IL-21 is the primary common gamma chain-binding cytokine required for human B-cell differentiation in vivo. Blood 118, 6824-6835 (2011).
61. Hacein-Bey-Abina, S. et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 363, 355-364 (2010).
62. Puel, A., Ziegler, S. F., Buckley, R. H. & Leonard, W. J. Defective IL7R expression in T-B+NK+ severe combined immunodeficiency. Nature Genet. 20, 394-397 (1998).
63. Dadi, H. K., Simon, A. J. & Roifman, C. M. Effect of CD3λ deficiency on maturation of α/β and γ/λ T-cell lineages in severe combined immunodeficiency. N. Engl. J. Med. 349, 1821-1828 (2003).
64. de Saint Basile, G. et al. Severe combined immunodeficiency caused by deficiency in either the λ or the ? subunit of CD3. J. Clin. Invest. 114, 1512-1517 (2004).
65. Rieux-Laucat, F. et al. Inherited and somatic CD3 mutations in a patient with T-cell deficiency. N. Engl. J. Med. 354, 1913-1921 (2006).
66. Greenberg, F. et al. Familial DiGeorge syndrome and associated partial monosomy of chromosome 22. Hum. Genet. 65, 317-319 (1984).
67. Elder, M. E. et al. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 264, 1596-1599 (1994).
68. Huck, K. et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J. Clin. Invest. 119, 1350-1358 (2009).
69. Hauck, F. et al. Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency. J. Allergy Clin. Immunol. 130, 1144-1152 e1111 (2012).
70. Lisowska-Grospierre, B. et al. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J. Clin. Invest. 76, 381-385 (1985).
71. Ma, C. S., Deenick, E. K., Batten, M. & Tangye, S. G. The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 209, 1241-1253 (2012).
72. Warnatz, K. et al. Human ICOS-deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107, 3045-3052 (2005).
73. Bossaller, L. et al. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J. Immunol. 177, 4927-4932 (2006).
74. Korthauer, U. et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539-541 (1993).
75. Litinskiy, M. B. et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nature Immunol. 3, 822-829 (2002).
76. Weller, S. et al. IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP-but not UNC-93B-deficient patients. Blood 120, 4992-5001 (2012).
77. Weller, S. et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl Acad. Sci. USA 98, 1166-1170 (2001).
78. Qi, H., Cannons, J. L., Klauschen, F., Schwartzberg, P. L. & Germain, R. N. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 455, 764-769 (2008).
79. Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462-469 (1998).
80. van Montfrans, J. M. et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J. Allergy Clin. Immunol. 129, 787-793.e6 (2012).
81. Salzer, E. et al. Combined immunodeficiency with life-threatening EBV-associatedlymphoproliferative disorder in patients lacking functional CD27. Haematologica 98, 473-478 (2012).
82. Ma, C. S. et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 119, 3997-4008 (2012).
83. Puga, I. et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nature Immunol. 13, 170-180 (2011).
84. Moir, S. et al. Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cells. Blood 120, 4850-4858 (2012).
85. Chapel, H. et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J. Allergy Clin. Immunol. 130, 1197-1198.e99 (2012).
86. Resnick, E. S., Moshier, E. L., Godbold, J. H. & Cunningham-Rundles, C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119, 1650-1657 (2012).
87. Orange, J. S. et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J. Allergy Clin. Immunol. 127, 1360-1367 e1366 (2011).
88. Brandtzaeg, P. & Johansen, F. E. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206, 32-63 (2005).
89. Salzer, U. et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nature Genet. 37, 820-828 (2005).
90. Castigli, E. et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nature Genet. 37, 829-834 (2005).
91. Rioux, J. D. et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc. Natl Acad. Sci. USA 106, 18680-18685 (2009).
92. Lefranc, M. P., Lefranc, G. & Rabbitts, T. H. Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals. Nature 300, 760-762 (1982).
93. Kruetzmann, S. et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197, 939-945 (2003).
94. Micol, R. et al. Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia. J. Allergy Clin. Immunol. 129, 770-777 (2012).
95. Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377 (2003).
96. Yoshizaki, A. et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491, 264-268 (2012).
97. Shlomchik, M. J., Marshak-Rothstein, A., Wolfowicz, C. B., Rothstein, T. L. & Weigert, M. G. The role of clonal selection and somatic mutation in autoimmunity. Nature 328, 805-811 (1987).
98. Durandy, A., Cantaert, T., Kracker, S. & Meffre, E. Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans. Autoimmunity 46, 148-156 (2012).
99. Hase, K. et al. Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease. PLoS ONE 3, e3033 (2008).
100. Rakhmanov, M. et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc. Natl Acad. Sci. USA 106, 13451-13456 (2009).
101. Isnardi, I. et al. Complement receptor 2/CD21-human naive B cells contain mostly autoreactive unresponsive clones. Blood 115, 5026-5036 (2010).
102. De Ravin, S. S. et al. Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood 116, 1263-1271 (2010).
103. Schuetz, C. et al. An immunodeficiency disease with RAG mutations and granulomas. N. Engl. J. Med. 358, 2030-2038 (2008).
104. Ombrello, M. J. et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N. Engl. J. Med. 366, 330-338 (2012).
105. Zhou, Q. et al. A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am. J. Hum. Genet. 91, 713-720 (2012).
106. Feske, S., Picard, C. & Fischer, A. Immunodeficiency due to mutations in ORAI1 and STIM1. Clin. Immunol. 135, 169-182 (2010).
107. Moratto, D. et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott- Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood 118, 1675-1684 (2011).
108. Hayward, A. R. et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 158, 977-983 (1997).
109. Jain, A. et al. Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand. Blood 118, 3811-3817 (2011).
110. Aiuti, A. et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N. Engl. J. Med. 360, 447-458 (2009).
111. Boztug, K. et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N. Engl. J. Med. 363, 1918-1927 (2010).
112. Kerns, H. M. et al. B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia. Blood 115, 2146-2155 (2010).
113. Dissing, J. & Knudsen, B. Adenosine-deaminase deficiency and combined immunodeficiency syndrome. Lancet 2, 1316 (1972).
114. Giblett, E. R., Anderson, J. E., Cohen, F., Pollara, B. & Meuwissen, H. J. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2, 1067-1069 (1972).
115. Lagresle-Peyrou, C. et al. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nature Genet. 41, 106-111 (2009).
116. Pannicke, U. et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nature Genet. 41, 101-105 (2009).
117. Nelson, N. D. & Bertuch, A. A. Dyskeratosis congenita as a disorder of telomere maintenance. Mutat. Res. 730, 43-51 (2012).
118. Dickinson, R. E. et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118, 2656-2658 (2011).
119. Moshous, D. et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J. Clin. Invest. 111, 381-387 (2003).
120. Schwarz, K. et al. RAG mutations in human B cell-negative SCID. Science 274, 97-99 (1996).